Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-07-20
    E.g., 2018-07-20

Articles

51281 items
12:00 AM, Aug 23, 2000  |  BC Extra | Company News

Chimeric appoints new CEO

Chimeric Therapies (Laguna Niguel, Calif.) appointed Virgil Thompson, formerly president and COO of Bio-Technology General (BTGC), as CEO. He replaces company co-founder Olav Bergheim, who will remain on the board....
12:00 AM, Aug 23, 2000  |  BC Extra | Company News

Provalis diabetes test approved

Provalis (LSE:PRO) received 510K approval to market its Glycosal point-of-care diabetes monitoring test in the U.S. The test measures HbA1c, a measure of long-term glucose levels. PRO was up 12p (59 percent) to 32.5p....
12:00 AM, Aug 23, 2000  |  BC Extra | Company News

KS Biomedix and Eukarion to develop antibodies

Eukarion (Bedford, Mass.) will use its lipidation technology to coat sheep monoclonal antibodies from KS Biomedix (LSE:KSB). KSB said the technology will allow its antibodies to enter cells and reach intracellular targets....
12:00 AM, Aug 23, 2000  |  BC Extra | Clinical News

Inex begins Phase II

Inex Pharmaceuticals (TSE:IEX) began a U.S. Phase II trial of its Onco TCS Transmembrane Carrier System (TCS) formulation of vincristine to treat small cell lung cancer. The trial is the first of three Phase II...
12:00 AM, Aug 23, 2000  |  BC Extra | Top Story

NIH's final guidelines on stem cell research

As expected, the NIH published guidelines detailing the procedures researchers are expected to follow to ensure that NIH-funded human pluripotent stem cell research is conducted in what the agency described as "an ethical and legal...
12:00 AM, Aug 23, 2000  |  BC Extra | Financial News

Alliance raises $10 million

ALLP raised $10 million through the sale of subordinated convertible debentures. The debentures are convertible into ALLP common stock at $13.32 per share. The investors have an option to buy an additional $10 million of...
12:00 AM, Aug 22, 2000  |  BC Extra | Financial News

Conversion completed for Alza notes

Holders converted $493 million worth of 5 percent convertible subordinated debentures due 2006 into 12.9 million AZA shares, representing a conversion price of $38.19 per share, or 26.18 shares per $1000 principal amount. AZA, was...
12:00 AM, Aug 22, 2000  |  BC Extra | Financial News

Dyax sells shoe

DYAX raised $9 million through the sale of 600,000 shares at $15 authorized to cover overallotments in its IPO earlier this month. The sale brings to $69 million the total raised in the offering, which...
12:00 AM, Aug 22, 2000  |  BC Extra | Financial News

Ista sells IPO

Ista (ISTA) raised $31.5 million through the sale of 3 million shares at $10.50 in its IPO. Underwriters CIBC World Markets; Prudential Vector Healthcare; and Thomas Weisel Partners have a 450,000-share overallotment option. ISTA, which...
12:00 AM, Aug 22, 2000  |  BC Extra | Company News

Beckman Coulter and Oncotech to develop cancer diagnostics

The companies will collaborate in the discovery of genetic markers for early stage malignancies in colon, ovarian, breast, prostate and lung cancers. BEC will contribute its automated sample preparation, DNA/RNA hybridization, immunochemistry and flow cytometry...

Pages